4.7 Article

Inhibition of IDO leads to IL-6-dependent systemic inflammation in mice when combined with photodynamic therapy

期刊

CANCER IMMUNOLOGY IMMUNOTHERAPY
卷 69, 期 6, 页码 1101-1112

出版社

SPRINGER
DOI: 10.1007/s00262-020-02528-5

关键词

Photodynamic therapy; Indoleamine 2; 3-dioxygenase 1; IL-6; Epacadostat

资金

  1. Polish National Science Centre [UMO-2014/13/D/NZ6/01080]
  2. European Commission [STREAM 692180]
  3. iONCO (Regionalna Inicjatywa Doskonalosci) from the Polish Ministry of Science and Higher Education

向作者/读者索取更多资源

It was previously reported that the activation of antitumor immune response by photodynamic therapy (PDT) is crucial for its therapeutic outcome. Excessive PDT-mediated inflammation is accompanied by immunosuppressive mechanisms that protect tissues from destruction. Thus, the final effect of PDT strongly depends on the balance between the activation of an adoptive arm of immune response and a range of activated immunosuppressive mechanisms. Here, with flow cytometry and functional tests, we evaluate the immunosuppressive activity of tumor-associated myeloid cells after PDT. We investigate the antitumor potential of PDT combined with indoleamine 2,3-dioxygenase 1 (IDO) inhibitor in the murine 4T1 and E0771 orthotopic breast cancer models. We found that the expression of IDO, elevated after PDT, affects the polarization of T regulatory cells and influences the innate immune response. Our results indicate that, depending on a therapeutic scheme, overcoming IDO-induced immunosuppressive mechanisms after PDT can be beneficial or can lead to a systemic toxic reaction. The inhibition of IDO, shortly after PDT, activates IL-6-dependent toxic reactions that can be diminished by the use of anti-IL-6 antibodies. Our results emphasize that deeper investigation of the physiological role of IDO, an attractive target for immunotherapies of cancer, is of great importance.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据